Prednisolone, Sulfacetamide

Metimyd Oph Sus

5 MG / ML + 100 MG / ML SuspensionCanadaCancelledAuthorised 31 Dec 1956

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Prednisolone, Sulfacetamide

Metimyd Oph Sus

5 MG / ML + 100 MG / ML SuspensionCanadaCancelledAuthorised 31 Dec 1956

Open in the registerAsk Osler about it

This page is kept for reference and is not offered to search engines.

In other countries

The same active substances on other registers, the same brand first.

Two medicines in one question?

Name two or more medicines and Osler runs an interaction check. A severe interaction is stated at the very top of the answer.

Discover Osler

Documents

The official texts, at the regulator.

Register entryHealth Canada

Sources and licences

Compiled by Prognia from the public register below; the register’s text is the official one.

Health Canada, Canada

Health Canada, Drug Product Database, drugproduct API, entire response observed 2026-10-10T15:12:07.336870+00:00; native facts projected by Prognia.

Licence: Open Government Licence Canada · Added 13 Oct 2026

Report an error or request removalCorrections from the holder or the register are welcome.

Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.

At a glance

Active substances: Prednisolone, Sulfacetamide
Strength: 5 MG / ML + 100 MG / ML
Dosage form: Suspension
Route: Ophthalmic
Register: Canada (Health Canada)
Status: Cancelled
Status in the register: Cancelled Post Market
Authorised: 31 Dec 1956
Registration: DIN 00177024
Marketing authorisation holder: Schering-Plough Canada INC
ATC code: S01CA02
Group: Sensory organs
Supply: PRESCRIPTION

Prednisolone/SulfacetamidePrednisolone + Sulfacetamide · 0.5 % / W/V + 10 % / W/V · SuspensionCanada

BlephamidePrednisolone + Sulfacetamide · 0.2 % + 10 % · DropsCanadaCancelled

Blephamide S.O.P.Prednisolone + Sulfacetamide · 0.2 % + 10 % · OintmentCanadaCancelled

Vasocidin Ophthalmic SolutionPrednisolone + Sulfacetamide · 2.5 MG / ML + 100 MG / ML · SolutionCanadaCancelled

Vasocidin Ophthalmic SolutionPrednisolone + Sulfacetamide · 2.5 MG / ML + 100 MG / ML · LiquidCanadaCancelled